This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Szulc P et al. (1996) Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture: a three year follow-up study. Bone 118: 487–488
Caraballo PJ et al. (1999) Changes in bone density after exposure to oral anticoagulants: a meta-analysis. Osteoporos Int 9: 441–448
Acknowledgements
The synopsis was written by Vicky Heath, Associate Editor, Nature Clinical Practice.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
Consultant for Eli Lilly, Procter and Gamble, Organon and Novartis.
Rights and permissions
About this article
Cite this article
Eastell, R. Does warfarin increase the risk of osteoporotic fracture?. Nat Rev Endocrinol 2, 484–485 (2006). https://doi.org/10.1038/ncpendmet0274
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ncpendmet0274